CBD in Indiana: Your Complete 2025 Legal Guide (Updated)

Indiana CBD Legal Guide

The landscape of Cannabidiol (CBD) products has expanded rapidly across the United States, and Indiana is no exception. Consumers in the Hoosier State show significant interest in CBD oils, edibles, topicals, and other hemp-derived goods. However, understanding the legal framework governing these products is crucial for both consumers and businesses. Yes, hemp-derived CBD is legal in Indiana as of 2025, but the state has established a specific and evolving set of rules that demand careful attention, particularly concerning Tetrahydrocannabinol (THC) content, allowable product types, and significant new regulations taking effect this year.

Navigating these regulations ensures compliance and helps consumers make informed, legal choices. Recent legislative actions, most notably Senate Bill 478 (SB 478), have introduced substantial updates impacting testing, labeling, age restrictions, and retail sales of certain hemp products. This guide provides a comprehensive overview of Indiana’s CBD laws for 2025, clarifying the current legal status, requirements, and restrictions.

Disclaimer: This article provides informational guidance based on Indiana laws and regulations as understood in mid-2025. It is not a substitute for professional legal advice. Laws and regulations are subject to change, and specific circumstances may require consultation with a qualified attorney.

The Foundation: Federal vs. Indiana Hemp Law

Understanding the legality of CBD in Indiana begins with recognizing the interplay between federal and state law. The federal government laid the groundwork for legal hemp, but states retain significant authority to regulate it within their borders.

The 2018 Farm Bill: A Federal Turning Point

The Agriculture Improvement Act of 2018, commonly known as the 2018 Farm Bill, marked a pivotal moment for hemp in the United States. This landmark legislation fundamentally changed federal policy by removing “hemp” from the definition of marijuana under the Controlled Substances Act (CSA). Critically, the bill defined hemp as the plant Cannabis sativa L. and any part of that plant, including derivatives, extracts, and cannabinoids, containing a delta-9 tetrahydrocannabinol (delta-9 THC) concentration of not more than 0.3%on a dry weight basis. Any cannabis plant material exceeding this precise $0.3\%$ delta-9 THC threshold remains classified as marijuana, a Schedule I controlled substance under federal law.

This federal descheduling legalized the cultivation, processing, transportation, and sale of hemp and hemp-derived products, provided they comply with the $0.3\%$ delta-9 THC limit and adhere to regulations established by the U.S. Department of Agriculture (USDA). The Farm Bill authorized states and Native American tribes to develop their own plans for regulating hemp production within their jurisdictions, subject to USDA approval. Importantly, it also included an interstate commerce provision, prohibiting states from interfering with the transportation of lawfully produced hemp products through their territory.

However, the 2018 Farm Bill explicitly preserved the authority of the Food and Drug Administration (FDA) to regulate cannabis and cannabis-derived compounds, including CBD, under the Federal Food, Drug, and Cosmetic (FD&C) Act. This means that marketing CBD products with therapeutic claims requires FDA approval, similar to any other drug. Furthermore, the FDA maintains that it is currently unlawful to introduce food containing added CBD or to market CBD as a dietary supplement in interstate commerce, although enforcement priorities have varied. The agency has approved only one cannabis-derived drug product, Epidiolex (a CBD oral solution for treating specific seizure disorders), and has permitted certain hemp seed ingredients (hulled hemp seeds, hemp seed protein, hemp seed oil) to be marketed in food, provided they comply with other requirements.

Indiana’s Response: Adoption and Adaptation

Following the federal government’s lead, Indiana moved to align its state laws with the 2018 Farm Bill. Senate Bill 52 (SB 52), signed into law in March 2018, was a crucial piece of legislation. It legalized the purchase, possession, and sale of “low THC hemp extract” across the state, defining it as a product derived from hemp containing not more than $0.3\%$ total delta-9 THC (including precursors) and no other controlled substances. This built upon earlier, more restrictive measures like House Bill 1148 (2017), which had allowed CBD oil access primarily for patients with treatment-resistant epilepsy.

The core statutory framework for hemp cultivation and processing in Indiana is found in Indiana Code Title 15, Chapter 15, Article 13 (IC 15-15-13). This law designates the Office of Indiana State Chemist (OISC), housed at Purdue University, as the lead agency responsible for licensing and regulating hemp growers and handlers (processors). Further legislation, Senate Bill 516 (SB 516) enacted in 2019, established the Indiana Hemp Advisory Committee to counsel the state seed commissioner and mandated that hemp vendors obtain a Seed Distribution Permit.

While Indiana adopted the federal $0.3\%$ delta-9 THC standard, the state quickly demonstrated its authority under the Farm Bill to implement stricter or more specific regulations. Early on, Indiana established stringent labeling and testing requirements for CBD products. SB 516 also effectively banned the retail sale of smokable hemp flower and prohibited smoking it in public. This legislative path highlights a pattern: Indiana initially embraced the federal definition of legal hemp but progressively layered state-specific controls. This trend appears driven by concerns emerging from the newly legal market, such as the proliferation of unregulated products, the rise of intoxicating hemp-derived isomers like Delta-8 THC, and potential risks to consumer safety and youth. The state’s response culminated in the comprehensive regulatory framework established by SB 478 in 2025, signaling a shift towards tighter state control over hemp derivatives, prioritizing regulation and consumer protection.

Federal vs. Indiana CBD Law: A 2025 Comparison

The following table provides a quick comparison of key aspects of federal and Indiana hemp/CBD law as of mid-2025:

The Crucial Detail: THC Limits in Indiana

The cornerstone of hemp legality, both federally and in Indiana, is the strict limit on delta-9 THC concentration. Understanding this limit and how it applies to different cannabinoids is essential.

The 0.3% Delta-9 THC Threshold

Indiana law mirrors the federal standard precisely: for a cannabis product to be considered legal hemp extract (CBD oil, tincture, edible, topical, etc.), it must contain no more than 0.3% total delta-9-tetrahydrocannabinol (THC), including precursors, by dry weight. This threshold is the definitive line separating legal hemp from illegal marijuana under state law. Any product exceeding this $0.3\%$ delta-9 THC limit is considered marijuana and is illegal to possess, sell, or manufacture in Indiana, which maintains strict anti-marijuana laws. Some sources also mention a minimum CBD content requirement (e.g., 5% or 10% CBD), although this is less consistently emphasized than the THC limit and may stem from earlier versions of the law. The primary focus remains the $0.3\%$ delta-9 THC ceiling. Testing results have shown that some products marketed as legal hemp in Indiana have actually exceeded this limit.

The Murky Waters of Delta-8 THC and Other Isomers

While the law is clear regarding delta-9 THC, the status of other hemp-derived cannabinoids, particularly psychoactive isomers like Delta-8 THC, Delta-10 THC, THC-O, and THC-P, has been considerably more complex and contentious in Indiana.

• Conflicting Interpretations: Several sources indicate that Delta-8 THC products derived from legal hemp are widely available and considered legal under the interpretation that the Farm Bill legalized all hemp derivatives, provided the final product meets the $0.3\%$ delta-9 THC limit. However, this interpretation is directly challenged by an official opinion from the Indiana Attorney General (issued prior to SB 478 but potentially still relevant). This opinion stated that THC variants like Delta-8, Delta-10, THC-O, and THC-P fall under the state’s definition of “Tetrahydrocannabinols,” classifying them as Schedule I controlled substances, irrespective of their source, unless they meet the narrow exception for low-THC hemp extract (i.e., ≤0.3% delta-9 THC and no other controlled substances).  Some sources explicitly state Delta-8 is banned, while others note Delta-10 is legal. This conflict creates significant legal ambiguity.
• SB 478’s Approach: The 2025 legislation, SB 478, does not explicitly legalize or ban these isomers. Instead, it acknowledges their presence in the market by establishing regulations around them.  Specifically, SB 478 prohibits the sale of low THC hemp extract containing Delta-8 THC, Delta-10 THC, HHC, THCo, THCp, or THCv to anyone under 21 years of age.  It also sets testing, packaging, and labeling requirements for “craft hemp flower products,” which may contain these cannabinoids if derived from compliant hemp flower.  Furthermore, SB 478 provides that “craft hemp flower product” is notincluded in the definition of “controlled substance analog,” “hashish,” “low THC hemp extract,” or “marijuana”.
• Ongoing Uncertainty: Despite SB 478’s regulatory framework, the fundamental conflict with the Attorney General’s opinion classifying these isomers as Schedule I controlled substances appears unresolved. Regulating a substance (setting age limits, testing rules) implicitly suggests some level of permissibility for compliant products, but it does not formally override a classification as an illegal controlled substance. This means that while the market for these products exists and is now subject to state regulation under SB 478, businesses and consumers may still face legal risks depending on future enforcement actions or court interpretations. The shift in some SB 478 language from “delta-9 THC” to simply “THC” could potentially broaden the scope of regulation but doesn’t clarify the core legality issue.  Consumers should exercise extreme caution with these products.

Permitted and Prohibited CBD Product Types

Indiana law allows a variety of hemp-derived CBD products, but places specific restrictions, most notably on smokable forms.

What’s Generally Legal for CBD in Indiana?

As long as products are derived from hemp and comply with the $0.3\%$ delta-9 THC limit and all testing/labeling requirements, the following types are generally legal for sale and possession in Indiana:

• CBD Oils and Tinctures: These common forms of CBD are widely available.
• Edibles: Gummies, capsules, and other food items infused with CBD are permitted.
• Topicals: Creams, lotions, balms, and salves containing CBD can be sold.
• Vape Products: CBD vape liquids are available, often found in vape shops and CBD stores.  SB 478 specifically includes “e-liquid” in its definition of regulated “craft hemp flower product”.
• Other Cannabinoids: Products containing other non-intoxicating cannabinoids like CBN (cannabinol) and CBG (cannabigerol) are generally legal, provided they meet the overall THC limit.

The Restriction on Smokable Hemp Flower

Indiana maintains a distinct stance against the retail sale of raw, smokable hemp flower, even if it meets the $0.3\%$ delta-9 THC threshold.

• Possession vs. Sale: While possessing hemp flower itself is technically legal for individuals ¹, selling it directly to consumers at retail is restricted or prohibited.
• Public Smoking Ban: Senate Bill 516 (2019) made smoking hemp flower in public a criminal offense, effectively curtailing its open use and sale.
• SB 478 Reinforcement: The 2025 law, SB 478, further solidifies this restriction. It defines “craft hemp flower” as the raw plant material intended for smoke inhalation.  However, it then defines the legal products derived from this flower (“craft hemp flower products”) as only gummies, edibles, tinctures, or e-liquids, explicitly excluding “smokable hemp” from this definition of products allowed for sale.  This structure permits the use of compliant flower as an ingredient for processing into other product types but prohibits selling the flower itself for smoking. Law enforcement may require individuals possessing hemp flower to prove its legality due to its resemblance to marijuana.

Ensuring Safety and Transparency: Testing, Labeling, and Packaging

Indiana places a strong emphasis on consumer protection through rigorous testing, labeling, and packaging requirements for CBD products. These rules aim to ensure product quality, verify THC content, and prevent misleading marketing.

Mandatory Testing Requirements

• THC Verification: All hemp grown in Indiana must be tested to ensure it meets the acceptable hemp THC level (defined as a delta-9 THC concentration of 0.3% or less, including measurement uncertainty).  Products sold at retail must also comply with this limit.
• SB 478 Testing for “Craft Hemp Flower Products”: This 2025 law mandates specific testing for products like gummies, edibles, tinctures, and e-liquids derived from craft hemp flower before distribution.  Distributors must obtain a Certificate of Analysis (COA) from an independent, ISO 17025-accredited laboratory.
• Comprehensive COA: The COA must verify:
  • The batch contains no more than $0.3\%$ delta-9 THC by weight.
  • The batch meets safety standards for contaminants, including specified limits for:
    • Heavy Metals: Cadmium, lead, arsenic, mercury.
    • Pesticides & Herbicides: Must not exceed acceptable levels.
    • Microbiological Contaminants: E. coli, Salmonella, mold.
    • Residual Solvents: Limits for solvents like butane, hexane, toluene.
  • The potency of cannabinoids, including THC and CBD percentages.
• OISC Oversight: The OISC oversees testing protocols for hemp cultivation, requiring specific sampling methods (sampling the top 5-8 inches of flower material) and chain-of-custody procedures. Testing must accurately identify total THC on a dry weight basis for cultivation compliance. (Note: While cultivation testing often uses “total THC,” retail product compliance under SB 52 and SB 478 focuses specifically on the $0.3\%$ delta-9 THC limit).

Strict Labeling and Packaging Rules

Indiana has notably strict labeling requirements, and retailers face penalties for non-compliance.

• QR Code Mandate: A key requirement established by SB 52 and reinforced by SB 478 is that every CBD product sold in Indiana must feature a scannable barcode or QR code on its label. This code must link to a document or website providing access to the product’s COA and other required batch information. This ensures transparency and allows consumers to verify product contents and safety.
• SB 478 Labeling Details: For “craft hemp flower products,” the information accessible via the QR code and potentially required on the label itself includes:
  • Batch identification number
  • Product name
  • Batch date and expiration date (max 2 years from harvest)
  • Batch size and total quantity produced
  • Ingredient list (including manufacturer/lot numbers)
  • Download link for the full COA
  • Website address for batch information
  • Net weight/volume (e.g., grams of craft hemp flower)
  • Producing facility identification
  • Statement confirming the product contains ≤0.3% delta-9 THC.
• Tamper-Evident Packaging: SB 478 mandates that craft hemp flower products be distributed in tamper-evident packaging, ensuring the product has not been opened or altered before purchase.  Possession of such products in a vehicle without intact tamper-evident packaging is a Class C misdemeanor.
• ATC Packaging Approval: Under SB 478, the Alcohol and Tobacco Commission (ATC) may review and approve packaging for craft hemp products. If the ATC doesn’t act within 30 days, the packaging is deemed approved.

The implementation of these detailed testing and labeling rules, particularly the QR code mandate and the comprehensive COA requirements under SB 478, reflects Indiana’s commitment to consumer safety in a market previously characterized by a lack of regulation. These measures aim to build consumer trust by providing verifiable information about product content and purity.

Licensing Requirements in Indiana

Indiana employs a multi-faceted licensing system for the hemp industry, distinguishing between cultivation/processing and retail sales.

Cultivation and Processing: OISC Licensing

Anyone intending to grow (cultivate) or handle (process, transport, store, manufacture) hemp in Indiana must obtain the appropriate license from the Office of Indiana State Chemist (OISC).

• License Types: The OISC issues Grower Licenses and Handler/Processor Licenses. Research licenses are also available for institutions. Selling hemp seed for sowing requires a licensed seedsman designation and a grower’s license. Transporting hemp for others generally requires a handler license.
• Application Process: Applications are submitted online via the OISC portal.   Applicants must provide detailed information, including personal/business details (name, address, contact, Tax ID/EIN), GPS coordinates of cultivation/processing sites, and intended purpose (CBD, fiber, grain).
• Background Checks: A crucial requirement is a criminal background check conducted by the FBI.  Federal law, adopted by Indiana, prohibits individuals with felony convictions related to controlled substances within the past 10 years from obtaining a hemp license, with limited exceptions for those participating under the 2014 Farm Bill pilot program. Key participants in a licensed business must also undergo these checks.
• Fees: As of recent reports, the application fee for either a grower or handler license is $750, payable online.  Obtaining both costs $1500.
• Compliance: Licensees must adhere to strict OISC regulations regarding record-keeping, site inspections, sampling, testing, and disposal/remediation of non-compliant crops (those exceeding the acceptable THC level).  Using certified hemp seed varieties with a history of compliance is advised.  Only EPA-approved pesticides registered with the OISC may be used.

Retail Sales: The New ATC Permit System (SB 478)

Prior to 2025, Indiana did not require a specific state-issued license for businesses to simply sell compliant hemp-derived CBD products at retail, making it relatively easy to open a CBD shop compared to other states. Retailers still needed standard business licenses and tax registration.

However, Senate Bill 478 introduces a significant change effective July 1, 2025. This law establishes a new regulatory framework for the retail sale of specific hemp products, placing oversight under the Indiana Alcohol and Tobacco Commission (ATC).

• Craft Hemp Retail Permit: Businesses selling “craft hemp flower products” (gummies, edibles, tinctures, e-liquids derived from craft hemp flower) and potentially other low-THC products regulated under the bill will need to obtain a retail craft hemp permit from the ATC.
• Permit Cap: The total number of these retail permits statewide is capped at 20,000. Earlier versions considered lower caps and restrictions on eligibility (e.g., excluding large grocery stores/drug stores).
• ATC Authority: The ATC is authorized to oversee permitting, enforce regulations (including age limits, advertising restrictions, packaging approval), and conduct inspections. This signifies a major shift, treating these hemp products more like alcohol and tobacco rather than purely agricultural commodities under OISC. This move likely reflects legislative intent to increase control over potentially intoxicating products and ensure more robust enforcement, potentially requiring additional ATC personnel.
• Permit Fees: The legislation proposes fees for these permits, potentially $1,000 for an initial two-year permit and $1,000 for renewal.
• Location Restrictions: SB 478 includes provisions prohibiting retailers with craft hemp permits from being located near schools. Establishments where craft hemp products account for a significant portion of sales (e.g., 85%) must prohibit minors from entering.
• On-Premise Consumption: Holders of both craft hemp retail permits and certain alcoholic beverage permits may serve craft hemp beverages in their original containers for on-site consumption.

This new ATC permit system represents a substantial increase in regulatory oversight for Indiana’s hemp retail market. It imposes new costs and compliance burdens on businesses, potentially favoring more established players and reflecting the state’s cautious approach to managing the availability of hemp-derived products, especially those with intoxicating potential.

Age Restrictions: Who Can Buy CBD in Indiana?

Age requirements for purchasing CBD and hemp products in Indiana have become more specific with recent legislation.

• General CBD (Pre-SB 478): Prior to the implementation of SB 478, Indiana state law did not establish a specific minimum age for purchasing general hemp-derived CBD products (like oils or topicals containing less than $0.3\%$ delta-9 THC). However, individual retailers often imposed their own age restrictions, commonly requiring customers to be 18 or 21.
• Delta-8/Delta-10 (Pre-SB 478): Even before SB 478, retailers selling Delta-8, Delta-9, and Delta-10 products often restricted sales to individuals 21 and older, similar to tobacco products.
• SB 478 Mandates (Effective July 1, 2025): Senate Bill 478 introduces mandatory age restrictions for specific product categories:
  • 21+ for Craft Hemp Flower Products: The sale or distribution of “craft hemp flower products” (gummies, edibles, tinctures, e-liquids derived from craft hemp flower) is prohibited to anyone under 21 years of age.  Purchasing or possessing these products by someone under 21 is a Class C infraction.
  • 21+ for Specific Low THC Extracts: The law explicitly prohibits selling or distributing low THC hemp extract containing Delta-8 THC, Delta-10 THC, HHC, THCo, THCp, or THCv to individuals under 21, whether in-person or online.
  • Age Verification: Retailers (including online sellers) must verify the age of consumers purchasing these restricted products using reliable methods, such as an online age verification service or by examining government-issued ID.
  • Enforcement: Selling these products to underage individuals is a Class C infraction for the retailer, with escalating civil penalties and potential permit suspension for repeat offenses.

The implementation of a mandatory 21+ age limit for these specific product categories under SB 478 is a clear response to concerns about youth access to potentially intoxicating hemp derivatives.

Penalties for Non-Compliance

Indiana enforces its hemp and CBD laws, and violations can result in significant consequences for individuals and businesses. Penalties vary depending on the nature of the violation, particularly whether the product involved meets the legal definition of hemp or is considered illegal marijuana due to excess THC.

• Possession/Sale of Non-Compliant Products (Excess THC): If a CBD product contains more than $0.3\%$ delta-9 THC, it is legally considered marijuana under Indiana law.  Possessing or selling such products carries the same penalties as marijuana offenses:
  • Possession: Possessing less than 30 grams of marijuana (or non-compliant CBD) is a Class B misdemeanor (up to 180 days jail, $1,000 fine) for a first offense. A prior drug offense elevates it to a Class A misdemeanor (up to 1 year jail, $5,000 fine). Possessing 30 grams or more with a prior offense is a Level 6 felony (6 months – 2.5 years prison, $10,000 fine).
  • Dealing: Selling less than 30 grams is a Class A misdemeanor for a first offense, becoming a Level 6 felony for subsequent offenses. Selling 30 grams to 10 pounds is a Level 6 felony. Selling over 10 pounds is a Level 5 felony (1-6 years prison, $10,000 fine). Penalties can be enhanced if dealing occurs near schools or involves minors.
• Labeling/Packaging Violations:
  • Retailers failing to follow Indiana’s strict labeling requirements (including the QR code) face penalties.  Selling Hemp Extract without proper labeling under SB 52 was established as a Class B infraction.
  • SB 478 makes distributing or selling a craft hemp flower product in violation of its testing, packaging, or labeling rules a Class B misdemeanor, escalating to a Class A misdemeanor for repeat offenses.
  • Possessing an open or non-tamper-evident container of a craft hemp flower product in a vehicle is a Class C misdemeanor.
• Age Restriction Violations (SB 478):
  • Selling craft hemp flower products or specified low-THC extracts (Delta-8, etc.) to someone under 21 is a Class C infraction for the retailer, with escalating civil penalties ($400-$2000) and potential permit suspension/revocation for multiple offenses within a year.
  • Purchasing or possessing these restricted products by someone under 21 is a Class C infraction.
• Unlicensed Activity: Growing or handling hemp without the required OISC license can result in penalties, including late fees ($750) in addition to application fees. Selling craft hemp products without the required ATC retail permit under SB 478 is also a crime.
• Synthetic Drugs: While distinct from hemp derivatives, it’s worth noting Indiana treats synthetic cannabinoids (“Spice,” “K2”) harshly, prosecuting offenses involving them similarly to Schedule I drugs, often as misdemeanors or felonies depending on the circumstances.

These penalties underscore the importance of sourcing CBD products from reputable vendors who rigorously test their products and adhere to Indiana’s labeling laws. Consumers should always check for QR codes and review COAs before purchasing. Retailers must ensure absolute compliance with THC limits, testing, labeling, packaging, and age verification rules to avoid severe consequences.

Recent Legislative Updates: Senate Bill 478 (2025)

The most significant recent development in Indiana’s hemp law is the passage and enactment of Senate Bill 478 during the 2025 legislative session. This comprehensive bill, which largely takes effect on July 1, 2025(with some provisions effective January 1, 2026, and one retroactive clause), establishes a detailed regulatory framework for certain hemp-derived products, particularly those marketed as “craft hemp flower products” and those containing specific THC isomers.

SB 478 was developed over several years and multiple attempts to regulate the burgeoning, and largely uncontrolled, market for hemp derivatives like Delta-8 THC.  Concerns about product safety (untested products, contaminants, inaccurate THC levels), misleading marketing, and youth access fueled the legislative effort.

Key provisions introduced or modified by SB 478 include:

• Defined Product Category: Creates regulations specifically for “craft hemp flower products” (gummies, edibles, tinctures, e-liquids derived from compliant hemp flower).
• Strict Testing: Mandates third-party lab testing (COAs) for potency (verifying ≤0.3% delta-9 THC) and contaminants (heavy metals, pesticides, microbes, solvents) for these products.
• Enhanced Labeling/Packaging: Requires tamper-evident packaging and detailed labeling, including a QR code linking to the COA and specific batch information.
• ATC Retail Permits: Transfers regulatory authority for retail sales of these products to the Alcohol and Tobacco Commission (ATC), requiring businesses to obtain a permit (capped at 20,000 statewide).
• 21+ Age Limit: Establishes a mandatory minimum age of 21 for purchasing craft hemp flower products and low-THC extracts containing Delta-8, Delta-10, HHC, THCo, THCp, or THCv.
• Advertising Restrictions: Includes provisions regulating the advertising of craft hemp products, particularly targeting youth.
• Smokable Flower Prohibition: Reinforces the prohibition on the retail sale of raw smokable hemp flower.
• Penalties: Establishes specific criminal penalties (misdemeanors and infractions) for violations related to packaging, labeling, age restrictions, and unlicensed sales.

SB 478 represents Indiana’s attempt to “rein in”  the hemp derivative market, providing clarity for law enforcement and implementing consumer protection measures while stopping short of legalizing marijuana. It reflects the state’s ongoing effort to balance the economic potential of hemp with public health and safety concerns.

Staying Compliant in 2025

Indiana’s legal landscape for hemp-derived CBD in 2025 is characterized by adherence to the federal $0.3\%$ delta-9 THC limit, coupled with increasingly specific state-level regulations. While basic CBD products like oils, edibles, and topicals remain legal and widely available, the state imposes strict requirements for testing, labeling (including mandatory QR codes linking to Certificates of Analysis), and packaging to ensure consumer safety and transparency.

The major development for 2025 is the implementation of Senate Bill 478, which creates a new regulatory structure under the Alcohol and Tobacco Commission for “craft hemp flower products” (gummies, edibles, tinctures, e-liquids) and other low-THC extracts. This includes mandatory 21+ age restrictions for these products, detailed testing and packaging rules, advertising limitations, and a new retail permitting system. The sale of raw smokable hemp flower remains prohibited at retail.

Significant ambiguity persists regarding the legal status of intoxicating isomers like Delta-8 THC. While SB 478 regulates their sale (imposing age limits), it doesn’t resolve the underlying conflict with the Attorney General’s opinion classifying them as controlled substances. This creates an environment where caution is paramount for both businesses and consumers dealing with these specific products.

For consumers, the key takeaways are to purchase CBD products only from reputable sources that provide verifiable third-party lab results (accessible via QR code) confirming compliance with the $0.3\%$ delta-9 THC limit and contaminant testing. Be aware of the 21+ age restriction for certain product types effective July 1, 2025. For businesses, strict adherence to all OISC (cultivation/processing) and ATC (retail) regulations, including licensing/permitting, testing, labeling, packaging, and age verification, is essential to operate legally and avoid significant penalties.

Indiana’s hemp laws continue to evolve as the state balances federal guidelines with its own public health and safety priorities. Staying informed about current regulations and any future legislative changes is crucial for anyone participating in the Indiana CBD market.

Disclaimer: The information contained in this article is intended for general educational and informational purposes only. It does not constitute legal advice, nor should it be relied upon as such. Cannabis laws in Indiana are complex, subject to interpretation, and may change over time. Readers are encouraged to conduct their own independent research. Reading this article does not create an attorney-client relationship. If you have specific legal questions or concerns about your situation, East Tree Dispensary strongly advises seeking counsel from a qualified attorney licensed in Indiana who can address your particular circumstances.

Come visit East Tree CBD, Downtown, Geist Crossing or Carmel